Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 3
2003 6
2004 2
2005 3
2007 4
2008 4
2009 1
2010 3
2011 4
2012 3
2013 2
2014 2
2015 4
2016 4
2017 8
2018 1
2019 4
2020 3
2021 6
2022 8
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. Among authors: polyakov s. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. Among authors: polyakov s. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial.
Vogelzang NJ, Beer TM, Gerritsen W, Oudard S, Wiechno P, Kukielka-Budny B, Samal V, Hajek J, Feyerabend S, Khoo V, Stenzl A, Csöszi T, Filipovic Z, Goncalves F, Prokhorov A, Cheung E, Hussain A, Sousa N, Bahl A, Hussain S, Fricke H, Kadlecova P, Scheiner T, Korolkiewicz RP, Bartunkova J, Spisek R; VIABLE Investigators. Vogelzang NJ, et al. JAMA Oncol. 2022 Apr 1;8(4):546-552. doi: 10.1001/jamaoncol.2021.7298. JAMA Oncol. 2022. PMID: 35142815 Free PMC article. Clinical Trial.
Synchronization and coexistence in quantum networks.
Burenkov IA, Semionov A, Hala, Gerrits T, Rahmouni A, Anand DJ, Li-Baboud YS, Slattery O, Battou A, Polyakov SV. Burenkov IA, et al. Among authors: polyakov sv. Opt Express. 2023 Mar 27;31(7):11431-11446. doi: 10.1364/OE.480486. Opt Express. 2023. PMID: 37155778 Free article.
Neural Correlates of Social Decision-Making.
Labutina N, Polyakov S, Nemtyreva L, Shuldishova A, Gizatullina O. Labutina N, et al. Among authors: polyakov s. Iran J Psychiatry. 2024 Jan;19(1):148-154. doi: 10.18502/ijps.v19i1.14350. Iran J Psychiatry. 2024. PMID: 38420275 Free PMC article.
Promising trends in authorship by Arab women in rheumatology.
Hmamouchi I, Ziadé N, El Kibbi L, Polyakov S, Arayssi T. Hmamouchi I, et al. Among authors: polyakov s. Lancet Rheumatol. 2022 Oct;4(10):e660-e662. doi: 10.1016/S2665-9913(22)00220-X. Lancet Rheumatol. 2022. PMID: 38265962 No abstract available.
Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial.
Bögemann M, Shore ND, Smith MR, Tammela TLJ, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Lebret T, Schostak M, Verholen F, Le Berre MA, Srinivasan S, Ortiz J, Mohamed AF, Sarapohja T, Fizazi K. Bögemann M, et al. Among authors: polyakov s. Eur Urol. 2023 Mar;83(3):212-221. doi: 10.1016/j.eururo.2022.07.018. Epub 2022 Sep 9. Eur Urol. 2023. PMID: 36089529 Free article. Clinical Trial.
New Series of Red-Light Phosphor Ca9-xZnxGd0.9(PO4)7:0.1Eu3+ (x = 0-1).
Dikhtyar YY, Spassky DA, Morozov VA, Polyakov SN, Romanova VD, Stefanovich SY, Deyneko DV, Baryshnikova OV, Nikiforov IV, Lazoryak BI. Dikhtyar YY, et al. Among authors: polyakov sn. Molecules. 2023 Jan 1;28(1):352. doi: 10.3390/molecules28010352. Molecules. 2023. PMID: 36615547 Free PMC article.
81 results